

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.89789273 |
| 2 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.89789273 |
| 3 | modulation by symbiont of host immune response (GO:0052553) | 6.89789273 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 6.89789273 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 6.89789273 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.89789273 |
| 7 | neutrophil activation involved in immune response (GO:0002283) | 5.74702547 |
| 8 | response to peptidoglycan (GO:0032494) | 5.70347263 |
| 9 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 5.39042126 |
| 10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.09441781 |
| 11 | macrophage activation involved in immune response (GO:0002281) | 5.05967814 |
| 12 | respiratory burst (GO:0045730) | 5.05333833 |
| 13 | response to host immune response (GO:0052572) | 4.72465901 |
| 14 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.72465901 |
| 15 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.60741587 |
| 16 | immunoglobulin mediated immune response (GO:0016064) | 4.59360715 |
| 17 | response to muramyl dipeptide (GO:0032495) | 4.42049483 |
| 18 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.28710930 |
| 19 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.24215865 |
| 20 | response to host (GO:0075136) | 4.24215865 |
| 21 | response to host defenses (GO:0052200) | 4.24215865 |
| 22 | neutrophil activation (GO:0042119) | 4.23932451 |
| 23 | granulocyte activation (GO:0036230) | 4.22256802 |
| 24 | neutrophil mediated immunity (GO:0002446) | 4.15697026 |
| 25 | positive regulation of interferon-alpha production (GO:0032727) | 4.15212944 |
| 26 | cellular extravasation (GO:0045123) | 4.08405605 |
| 27 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.04224024 |
| 28 | leukocyte aggregation (GO:0070486) | 4.01155073 |
| 29 | regulation of mast cell degranulation (GO:0043304) | 3.96468756 |
| 30 | regulation of interferon-alpha production (GO:0032647) | 3.93017202 |
| 31 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.91985107 |
| 32 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.82615394 |
| 33 | positive regulation of mast cell activation (GO:0033005) | 3.81609986 |
| 34 | positive regulation of mast cell degranulation (GO:0043306) | 3.81583437 |
| 35 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.81583437 |
| 36 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.80215510 |
| 37 | myeloid cell activation involved in immune response (GO:0002275) | 3.79828383 |
| 38 | negative regulation of interleukin-12 production (GO:0032695) | 3.74713793 |
| 39 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.73180252 |
| 40 | positive regulation of antigen processing and presentation (GO:0002579) | 3.73108733 |
| 41 | microglial cell activation (GO:0001774) | 3.71388282 |
| 42 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.69973210 |
| 43 | negative regulation of cell killing (GO:0031342) | 3.69973210 |
| 44 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.68594548 |
| 45 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.63939963 |
| 46 | superoxide anion generation (GO:0042554) | 3.57092440 |
| 47 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.56657673 |
| 48 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.56657673 |
| 49 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.54239652 |
| 50 | reactive oxygen species biosynthetic process (GO:1903409) | 3.53461113 |
| 51 | macrophage activation (GO:0042116) | 3.51501229 |
| 52 | response to fungus (GO:0009620) | 3.49981319 |
| 53 | regulation of mast cell activation (GO:0033003) | 3.48987476 |
| 54 | regulation of leukocyte degranulation (GO:0043300) | 3.44406307 |
| 55 | negative regulation of mast cell activation (GO:0033004) | 3.43957852 |
| 56 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.43328528 |
| 57 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.42314986 |
| 58 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.36206458 |
| 59 | detection of molecule of bacterial origin (GO:0032490) | 3.36096231 |
| 60 | T-helper 1 type immune response (GO:0042088) | 3.32149809 |
| 61 | apoptotic cell clearance (GO:0043277) | 3.32141965 |
| 62 | DNA deamination (GO:0045006) | 3.30273474 |
| 63 | positive regulation of B cell differentiation (GO:0045579) | 3.28561878 |
| 64 | leukotriene metabolic process (GO:0006691) | 3.25682024 |
| 65 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.25167571 |
| 66 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.24339172 |
| 67 | leukocyte mediated cytotoxicity (GO:0001909) | 3.21421721 |
| 68 | neutrophil chemotaxis (GO:0030593) | 3.21014255 |
| 69 | B cell mediated immunity (GO:0019724) | 3.20815630 |
| 70 | detection of other organism (GO:0098543) | 3.19108780 |
| 71 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.18340732 |
| 72 | defense response to protozoan (GO:0042832) | 3.17867933 |
| 73 | myeloid leukocyte mediated immunity (GO:0002444) | 3.17277557 |
| 74 | myeloid dendritic cell differentiation (GO:0043011) | 3.16285156 |
| 75 | regulation of antigen processing and presentation (GO:0002577) | 3.14804862 |
| 76 | myeloid dendritic cell activation (GO:0001773) | 3.11867001 |
| 77 | neutrophil migration (GO:1990266) | 3.11475112 |
| 78 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.08235494 |
| 79 | indolalkylamine catabolic process (GO:0046218) | 3.07899803 |
| 80 | tryptophan catabolic process (GO:0006569) | 3.07899803 |
| 81 | indole-containing compound catabolic process (GO:0042436) | 3.07899803 |
| 82 | positive regulation of interferon-beta production (GO:0032728) | 3.07703399 |
| 83 | cellular response to type I interferon (GO:0071357) | 3.07412123 |
| 84 | type I interferon signaling pathway (GO:0060337) | 3.07412123 |
| 85 | response to type I interferon (GO:0034340) | 3.06447170 |
| 86 | positive regulation of leukocyte degranulation (GO:0043302) | 3.04223870 |
| 87 | detection of external biotic stimulus (GO:0098581) | 3.02718895 |
| 88 | regulation of B cell differentiation (GO:0045577) | 3.02700094 |
| 89 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.00309457 |
| 90 | leukocyte cell-cell adhesion (GO:0007159) | 3.00229838 |
| 91 | interferon-gamma secretion (GO:0072643) | 2.99967277 |
| 92 | germinal center formation (GO:0002467) | 2.99095500 |
| 93 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.98524100 |
| 94 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.98219403 |
| 95 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.97450385 |
| 96 | cellular response to zinc ion (GO:0071294) | 2.97156693 |
| 97 | positive regulation of defense response to virus by host (GO:0002230) | 2.96732344 |
| 98 | negative regulation of granulocyte differentiation (GO:0030853) | 2.96607107 |
| 99 | myeloid leukocyte activation (GO:0002274) | 2.96308224 |
| 100 | cellular response to exogenous dsRNA (GO:0071360) | 2.95395361 |
| 101 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.94175416 |
| 102 | natural killer cell mediated immunity (GO:0002228) | 2.92939704 |
| 103 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.92939704 |
| 104 | regulation of gamma-delta T cell activation (GO:0046643) | 2.92399967 |
| 105 | phagosome maturation (GO:0090382) | 2.91935751 |
| 106 | negative regulation of T cell mediated immunity (GO:0002710) | 2.91247782 |
| 107 | regulation of germinal center formation (GO:0002634) | 2.91000946 |
| 108 | regulation of integrin activation (GO:0033623) | 2.90322083 |
| 109 | detection of bacterium (GO:0016045) | 2.88584609 |
| 110 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.86997714 |
| 111 | kynurenine metabolic process (GO:0070189) | 2.86380736 |
| 112 | negative regulation of interleukin-17 production (GO:0032700) | 2.85703007 |
| 113 | NIK/NF-kappaB signaling (GO:0038061) | 2.85606565 |
| 114 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.85556446 |
| 115 | regulation of interleukin-12 production (GO:0032655) | 2.85400575 |
| 116 | pinocytosis (GO:0006907) | 2.84994572 |
| 117 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.84842627 |
| 118 | granulocyte chemotaxis (GO:0071621) | 2.84415012 |
| 119 | negative regulation of interleukin-6 production (GO:0032715) | 2.83592850 |
| 120 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.83434850 |
| 121 | interferon-gamma production (GO:0032609) | 2.82878456 |
| 122 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.82830381 |
| 123 | regulation of regulated secretory pathway (GO:1903305) | 2.82187834 |
| 124 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.82162479 |
| 125 | response to protozoan (GO:0001562) | 2.81921450 |
| 126 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.81539898 |
| 127 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.77447122 |
| 128 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.77096963 |
| 129 | negative regulation of interleukin-1 production (GO:0032692) | 2.75361407 |
| 130 | detection of biotic stimulus (GO:0009595) | 2.72626066 |
| 131 | tryptophan metabolic process (GO:0006568) | 2.71287151 |
| 132 | regulation of hypersensitivity (GO:0002883) | 2.70734081 |
| 133 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.70636164 |
| 134 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.69742617 |
| 135 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.69376691 |
| 136 | regulation of T cell tolerance induction (GO:0002664) | 2.69144215 |
| 137 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.67529563 |
| 138 | dendritic cell chemotaxis (GO:0002407) | 2.66609325 |
| 139 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.66505021 |
| 140 | negative regulation of innate immune response (GO:0045824) | 2.63965748 |
| 141 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.62840022 |
| 142 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.62283613 |
| 143 | regulation of tolerance induction (GO:0002643) | 2.59598359 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.31158661 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.86800270 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.65038006 |
| 4 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.39221224 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.37002856 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.87073205 |
| 7 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.78169159 |
| 8 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.76635475 |
| 9 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.63966094 |
| 10 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.45607671 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.37535511 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.23041279 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.13244833 |
| 14 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.70794110 |
| 15 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.67161809 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.66088447 |
| 17 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.61385621 |
| 18 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.59078633 |
| 19 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.57533474 |
| 20 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.55097516 |
| 21 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.49554277 |
| 22 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.40663477 |
| 23 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.37546625 |
| 24 | SPI1_23127762_ChIP-Seq_K562_Human | 2.32783061 |
| 25 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.27640297 |
| 26 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.19776426 |
| 27 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.18314602 |
| 28 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.15945104 |
| 29 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.07238519 |
| 30 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.05017471 |
| 31 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.03811458 |
| 32 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.94821896 |
| 33 | MAF_26560356_Chip-Seq_TH1_Human | 1.88440475 |
| 34 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86833339 |
| 35 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.84709794 |
| 36 | MYB_26560356_Chip-Seq_TH2_Human | 1.83118788 |
| 37 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.80906680 |
| 38 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.78514592 |
| 39 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.78494427 |
| 40 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.73403959 |
| 41 | MYC_22102868_ChIP-Seq_BL_Human | 1.73050106 |
| 42 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.72206204 |
| 43 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.71866456 |
| 44 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.69831360 |
| 45 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.68361814 |
| 46 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.68000588 |
| 47 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.67853864 |
| 48 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.66414625 |
| 49 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.56962138 |
| 50 | MYB_26560356_Chip-Seq_TH1_Human | 1.56893654 |
| 51 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.55967725 |
| 52 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.55185003 |
| 53 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50726044 |
| 54 | UTX_26944678_Chip-Seq_JUKART_Human | 1.49720272 |
| 55 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.44617033 |
| 56 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.42203720 |
| 57 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.41873030 |
| 58 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.39145289 |
| 59 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.38250212 |
| 60 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.35102268 |
| 61 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34906984 |
| 62 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.34426558 |
| 63 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.31343669 |
| 64 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.29120494 |
| 65 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25923583 |
| 66 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.25735922 |
| 67 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25504383 |
| 68 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.24426132 |
| 69 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.22476487 |
| 70 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.20493335 |
| 71 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.20290171 |
| 72 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.20005182 |
| 73 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.19713474 |
| 74 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.17940678 |
| 75 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.17531118 |
| 76 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.17299568 |
| 77 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.15837753 |
| 78 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14236079 |
| 79 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.13608735 |
| 80 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.12624313 |
| 81 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.09713363 |
| 82 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.09706529 |
| 83 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.09516903 |
| 84 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.09117367 |
| 85 | GATA3_26560356_Chip-Seq_TH2_Human | 1.07404819 |
| 86 | GATA1_22025678_ChIP-Seq_K562_Human | 1.05318542 |
| 87 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.05089847 |
| 88 | MAF_26560356_Chip-Seq_TH2_Human | 1.04975314 |
| 89 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.03994958 |
| 90 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.03005351 |
| 91 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.01791890 |
| 92 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.01311036 |
| 93 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97557804 |
| 94 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.97279981 |
| 95 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.96225544 |
| 96 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.95542116 |
| 97 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.94764970 |
| 98 | VDR_22108803_ChIP-Seq_LS180_Human | 0.94084768 |
| 99 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.93818835 |
| 100 | GATA1_19941826_ChIP-Seq_K562_Human | 0.93776804 |
| 101 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.93508847 |
| 102 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93280138 |
| 103 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.92380435 |
| 104 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89895152 |
| 105 | GATA2_19941826_ChIP-Seq_K562_Human | 0.89797095 |
| 106 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.89387295 |
| 107 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.89097958 |
| 108 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.88569759 |
| 109 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87406514 |
| 110 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.86537897 |
| 111 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.86267843 |
| 112 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.85133222 |
| 113 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.84637447 |
| 114 | P300_27268052_Chip-Seq_Bcells_Human | 0.84142310 |
| 115 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.83722291 |
| 116 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.82596687 |
| 117 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.82498320 |
| 118 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.81135679 |
| 119 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.80734834 |
| 120 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.79873305 |
| 121 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.79801622 |
| 122 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.79392154 |
| 123 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.76684494 |
| 124 | NCOR_22424771_ChIP-Seq_293T_Human | 0.76098945 |
| 125 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.76003631 |
| 126 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75489469 |
| 127 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.73575115 |
| 128 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.71673420 |
| 129 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.68125716 |
| 130 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.66827882 |
| 131 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.62269401 |
| 132 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.62071559 |
| 133 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.61024875 |
| 134 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.60853053 |
| 135 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.60851081 |
| 136 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.60795399 |
| 137 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.59545985 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 4.17416534 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.06205664 |
| 3 | MP0003436_decreased_susceptibility_to | 4.02177639 |
| 4 | MP0005058_abnormal_lysosome_morphology | 3.46228120 |
| 5 | MP0002419_abnormal_innate_immunity | 3.41373162 |
| 6 | MP0004510_myositis | 3.30698513 |
| 7 | MP0009785_altered_susceptibility_to | 3.05458466 |
| 8 | MP0002148_abnormal_hypersensitivity_rea | 3.04787601 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.99235628 |
| 10 | MP0003172_abnormal_lysosome_physiology | 2.98491647 |
| 11 | MP0005025_abnormal_response_to | 2.90387578 |
| 12 | MP0001790_abnormal_immune_system | 2.89128510 |
| 13 | MP0005387_immune_system_phenotype | 2.89128510 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.67252309 |
| 15 | MP0000685_abnormal_immune_system | 2.59137832 |
| 16 | MP0006082_CNS_inflammation | 2.57236267 |
| 17 | MP0003724_increased_susceptibility_to | 2.54126196 |
| 18 | MP0001800_abnormal_humoral_immune | 2.48415288 |
| 19 | MP0000569_abnormal_digit_pigmentation | 2.43989782 |
| 20 | MP0002723_abnormal_immune_serum | 2.42782861 |
| 21 | MP0009278_abnormal_bone_marrow | 2.37525678 |
| 22 | MP0003183_abnormal_peptide_metabolism | 2.37411641 |
| 23 | MP0001819_abnormal_immune_cell | 2.30168466 |
| 24 | MP0002420_abnormal_adaptive_immunity | 2.28573684 |
| 25 | MP0005464_abnormal_platelet_physiology | 2.28550317 |
| 26 | MP0001533_abnormal_skeleton_physiology | 2.14221628 |
| 27 | MP0005671_abnormal_response_to | 2.09799094 |
| 28 | MP0002405_respiratory_system_inflammati | 2.06027920 |
| 29 | MP0009840_abnormal_foam_cell | 1.99943437 |
| 30 | MP0003191_abnormal_cellular_cholesterol | 1.99456234 |
| 31 | MP0004947_skin_inflammation | 1.91847127 |
| 32 | MP0002653_abnormal_ependyma_morphology | 1.89758478 |
| 33 | MP0001845_abnormal_inflammatory_respons | 1.84032238 |
| 34 | MP0005174_abnormal_tail_pigmentation | 1.82610603 |
| 35 | MP0001853_heart_inflammation | 1.82365900 |
| 36 | MP0003195_calcinosis | 1.77716885 |
| 37 | MP0003300_gastrointestinal_ulcer | 1.70899496 |
| 38 | MP0003075_altered_response_to | 1.68390618 |
| 39 | MP0000716_abnormal_immune_system | 1.67640867 |
| 40 | MP0005397_hematopoietic_system_phenotyp | 1.66556571 |
| 41 | MP0001545_abnormal_hematopoietic_system | 1.66556571 |
| 42 | MP0000343_altered_response_to | 1.65499696 |
| 43 | MP0003448_altered_tumor_morphology | 1.63316243 |
| 44 | MP0002398_abnormal_bone_marrow | 1.57883349 |
| 45 | MP0008469_abnormal_protein_level | 1.57683912 |
| 46 | MP0005310_abnormal_salivary_gland | 1.57236214 |
| 47 | MP0001851_eye_inflammation | 1.51121068 |
| 48 | MP0005076_abnormal_cell_differentiation | 1.50649739 |
| 49 | MP0010155_abnormal_intestine_physiology | 1.47761600 |
| 50 | MP0000689_abnormal_spleen_morphology | 1.41891851 |
| 51 | MP0009333_abnormal_splenocyte_physiolog | 1.39841026 |
| 52 | MP0002998_abnormal_bone_remodeling | 1.35696287 |
| 53 | MP0002429_abnormal_blood_cell | 1.35657971 |
| 54 | MP0002132_abnormal_respiratory_system | 1.32296127 |
| 55 | MP0009764_decreased_sensitivity_to | 1.31726277 |
| 56 | MP0000465_gastrointestinal_hemorrhage | 1.30559325 |
| 57 | MP0004130_abnormal_muscle_cell | 1.28021930 |
| 58 | MP0002722_abnormal_immune_system | 1.27022091 |
| 59 | MP0002006_tumorigenesis | 1.24658664 |
| 60 | MP0002166_altered_tumor_susceptibility | 1.24516029 |
| 61 | MP0009765_abnormal_xenobiotic_induced | 1.23283964 |
| 62 | MP0005670_abnormal_white_adipose | 1.23036170 |
| 63 | MP0003646_muscle_fatigue | 1.22085301 |
| 64 | MP0000604_amyloidosis | 1.20844856 |
| 65 | MP0000858_altered_metastatic_potential | 1.19074277 |
| 66 | MP0003806_abnormal_nucleotide_metabolis | 1.15687265 |
| 67 | MP0001873_stomach_inflammation | 1.14542566 |
| 68 | MP0001485_abnormal_pinna_reflex | 1.12763592 |
| 69 | MP0002933_joint_inflammation | 1.10859973 |
| 70 | MP0003690_abnormal_glial_cell | 1.09525170 |
| 71 | MP0003566_abnormal_cell_adhesion | 1.07163486 |
| 72 | MP0010307_abnormal_tumor_latency | 1.05959660 |
| 73 | MP0005166_decreased_susceptibility_to | 1.05858454 |
| 74 | MP0000516_abnormal_urinary_system | 1.05736950 |
| 75 | MP0005367_renal/urinary_system_phenotyp | 1.05736950 |
| 76 | MP0003828_pulmonary_edema | 1.05326712 |
| 77 | MP0008260_abnormal_autophagy | 1.02942960 |
| 78 | MP0005390_skeleton_phenotype | 1.01747228 |
| 79 | MP0002396_abnormal_hematopoietic_system | 1.01537407 |
| 80 | MP0000015_abnormal_ear_pigmentation | 1.01459622 |
| 81 | MP0004808_abnormal_hematopoietic_stem | 1.01318684 |
| 82 | MP0002876_abnormal_thyroid_physiology | 0.95549171 |
| 83 | MP0002139_abnormal_hepatobiliary_system | 0.95158376 |
| 84 | MP0000371_diluted_coat_color | 0.91994344 |
| 85 | MP0001986_abnormal_taste_sensitivity | 0.91705848 |
| 86 | MP0005167_abnormal_blood-brain_barrier | 0.91397401 |
| 87 | MP0009763_increased_sensitivity_to | 0.84434613 |
| 88 | MP0000490_abnormal_crypts_of | 0.83949707 |
| 89 | MP0005075_abnormal_melanosome_morpholog | 0.81688398 |
| 90 | MP0004782_abnormal_surfactant_physiolog | 0.80286294 |
| 91 | MP0003866_abnormal_defecation | 0.80248367 |
| 92 | MP0008877_abnormal_DNA_methylation | 0.78463325 |
| 93 | MP0002138_abnormal_hepatobiliary_system | 0.77470594 |
| 94 | MP0002837_dystrophic_cardiac_calcinosis | 0.75932423 |
| 95 | MP0001663_abnormal_digestive_system | 0.75204900 |
| 96 | MP0003656_abnormal_erythrocyte_physiolo | 0.73223701 |
| 97 | MP0003795_abnormal_bone_structure | 0.71806398 |
| 98 | MP0005164_abnormal_response_to | 0.71667827 |
| 99 | MP0002277_abnormal_respiratory_mucosa | 0.71263604 |
| 100 | MP0000249_abnormal_blood_vessel | 0.71206059 |
| 101 | MP0004381_abnormal_hair_follicle | 0.69823644 |
| 102 | MP0003011_delayed_dark_adaptation | 0.69747880 |
| 103 | MP0008872_abnormal_physiological_respon | 0.69035875 |
| 104 | MP0005084_abnormal_gallbladder_morpholo | 0.67261154 |
| 105 | MP0005257_abnormal_intraocular_pressure | 0.67149939 |
| 106 | MP0000703_abnormal_thymus_morphology | 0.65963101 |
| 107 | MP0001501_abnormal_sleep_pattern | 0.64043045 |
| 108 | MP0003453_abnormal_keratinocyte_physiol | 0.62896571 |
| 109 | MP0001958_emphysema | 0.62017243 |
| 110 | MP0005647_abnormal_sex_gland | 0.59216309 |
| 111 | MP0008961_abnormal_basal_metabolism | 0.58009292 |
| 112 | MP0003763_abnormal_thymus_physiology | 0.54022562 |
| 113 | MP0003091_abnormal_cell_migration | 0.53927579 |
| 114 | MP0002254_reproductive_system_inflammat | 0.53891829 |
| 115 | MP0002693_abnormal_pancreas_physiology | 0.53592659 |
| 116 | MP0009115_abnormal_fat_cell | 0.53353499 |
| 117 | MP0005334_abnormal_fat_pad | 0.52419395 |
| 118 | MP0002136_abnormal_kidney_physiology | 0.51904417 |
| 119 | MP0008004_abnormal_stomach_pH | 0.50767219 |
| 120 | MP0008873_increased_physiological_sensi | 0.49775937 |
| 121 | MP0000767_abnormal_smooth_muscle | 0.46898088 |
| 122 | MP0002928_abnormal_bile_duct | 0.43691803 |
| 123 | MP0005621_abnormal_cell_physiology | 0.43334786 |
| 124 | MP0004883_abnormal_blood_vessel | 0.42682255 |
| 125 | MP0004185_abnormal_adipocyte_glucose | 0.42518355 |
| 126 | MP0005023_abnormal_wound_healing | 0.42416210 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 7.83682708 |
| 2 | Eczematoid dermatitis (HP:0000976) | 7.15001170 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 7.04720907 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.49101466 |
| 5 | Abnormality of macrophages (HP:0004311) | 5.21467282 |
| 6 | Vacuolated lymphocytes (HP:0001922) | 4.78899651 |
| 7 | Mediastinal lymphadenopathy (HP:0100721) | 4.69962126 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.56593747 |
| 9 | Recurrent skin infections (HP:0001581) | 4.50081056 |
| 10 | Systemic lupus erythematosus (HP:0002725) | 4.49578171 |
| 11 | Increased cerebral lipofuscin (HP:0011813) | 4.48429294 |
| 12 | Gingivitis (HP:0000230) | 4.36873071 |
| 13 | Recurrent fungal infections (HP:0002841) | 4.22112501 |
| 14 | Obstructive lung disease (HP:0006536) | 4.15107368 |
| 15 | Chronic obstructive pulmonary disease (HP:0006510) | 4.15107368 |
| 16 | Myositis (HP:0100614) | 4.10980105 |
| 17 | Dysostosis multiplex (HP:0000943) | 3.85400025 |
| 18 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.83958698 |
| 19 | Abnormality of glycolipid metabolism (HP:0010969) | 3.77678888 |
| 20 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.77678888 |
| 21 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.77678888 |
| 22 | Orchitis (HP:0100796) | 3.73219636 |
| 23 | Stomatitis (HP:0010280) | 3.62743643 |
| 24 | Periodontitis (HP:0000704) | 3.57408396 |
| 25 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.46516828 |
| 26 | Recurrent cutaneous fungal infections (HP:0011370) | 3.46516828 |
| 27 | Autoimmune thrombocytopenia (HP:0001973) | 3.36263976 |
| 28 | Cellulitis (HP:0100658) | 3.33802674 |
| 29 | Retrobulbar optic neuritis (HP:0100654) | 3.27300739 |
| 30 | Optic neuritis (HP:0100653) | 3.27300739 |
| 31 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 3.23352694 |
| 32 | Short 1st metacarpal (HP:0010034) | 3.23352694 |
| 33 | Recurrent viral infections (HP:0004429) | 3.17527640 |
| 34 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.08635425 |
| 35 | Mucopolysacchariduria (HP:0008155) | 3.08635425 |
| 36 | Vasculitis (HP:0002633) | 3.04996559 |
| 37 | Panhypogammaglobulinemia (HP:0003139) | 3.04965234 |
| 38 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.01197096 |
| 39 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.01197096 |
| 40 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.01197096 |
| 41 | Interstitial pulmonary disease (HP:0006530) | 2.91806159 |
| 42 | Meningitis (HP:0001287) | 2.91511345 |
| 43 | Axonal loss (HP:0003447) | 2.90331559 |
| 44 | Glomerulonephritis (HP:0000099) | 2.89931206 |
| 45 | Urticaria (HP:0001025) | 2.89373971 |
| 46 | Pustule (HP:0200039) | 2.83301794 |
| 47 | Loss of speech (HP:0002371) | 2.80611718 |
| 48 | Abnormality of the 1st metacarpal (HP:0010009) | 2.80329803 |
| 49 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.79704452 |
| 50 | Encephalitis (HP:0002383) | 2.76514132 |
| 51 | Chronic otitis media (HP:0000389) | 2.73960312 |
| 52 | Keratoconjunctivitis (HP:0001096) | 2.72339355 |
| 53 | Disinhibition (HP:0000734) | 2.71134415 |
| 54 | T lymphocytopenia (HP:0005403) | 2.69381222 |
| 55 | Abnormality of T cell number (HP:0011839) | 2.68226802 |
| 56 | Abolished electroretinogram (ERG) (HP:0000550) | 2.65833871 |
| 57 | Stenosis of the external auditory canal (HP:0000402) | 2.62560662 |
| 58 | Osteomyelitis (HP:0002754) | 2.57123812 |
| 59 | Leukocytosis (HP:0001974) | 2.54900741 |
| 60 | Gastrointestinal infarctions (HP:0005244) | 2.49985170 |
| 61 | Hematochezia (HP:0002573) | 2.49828144 |
| 62 | Pulmonary infiltrates (HP:0002113) | 2.47567155 |
| 63 | Spontaneous hematomas (HP:0007420) | 2.47366183 |
| 64 | Basal ganglia calcification (HP:0002135) | 2.46901892 |
| 65 | Carpal bone hypoplasia (HP:0001498) | 2.46890359 |
| 66 | Prostate neoplasm (HP:0100787) | 2.46090184 |
| 67 | Colitis (HP:0002583) | 2.44681288 |
| 68 | Petechiae (HP:0000967) | 2.42822078 |
| 69 | Inflammation of the large intestine (HP:0002037) | 2.42156544 |
| 70 | Hemoptysis (HP:0002105) | 2.36354946 |
| 71 | Recurrent pneumonia (HP:0006532) | 2.36043157 |
| 72 | Abnormality of the pleura (HP:0002103) | 2.33961121 |
| 73 | Abnormality of B cell number (HP:0010975) | 2.33216958 |
| 74 | Gingival bleeding (HP:0000225) | 2.32959711 |
| 75 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.32951826 |
| 76 | J-shaped sella turcica (HP:0002680) | 2.31125521 |
| 77 | IgM deficiency (HP:0002850) | 2.30813595 |
| 78 | Gastrointestinal inflammation (HP:0004386) | 2.29919463 |
| 79 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.28820989 |
| 80 | Pendular nystagmus (HP:0012043) | 2.27674606 |
| 81 | Joint hemorrhage (HP:0005261) | 2.27583418 |
| 82 | Amyloidosis (HP:0011034) | 2.26518448 |
| 83 | Pathologic fracture (HP:0002756) | 2.26163500 |
| 84 | Epistaxis (HP:0000421) | 2.24568273 |
| 85 | Congenital stationary night blindness (HP:0007642) | 2.24525018 |
| 86 | Arterial thrombosis (HP:0004420) | 2.24149853 |
| 87 | Abnormality of eosinophils (HP:0001879) | 2.22858886 |
| 88 | Prolonged bleeding time (HP:0003010) | 2.22717759 |
| 89 | Mutism (HP:0002300) | 2.22114573 |
| 90 | Thick nail (HP:0001805) | 2.20388213 |
| 91 | Cheilitis (HP:0100825) | 2.19824837 |
| 92 | Ectopic kidney (HP:0000086) | 2.19462725 |
| 93 | Thyroiditis (HP:0100646) | 2.16455054 |
| 94 | Thoracic kyphosis (HP:0002942) | 2.15527980 |
| 95 | Nasal polyposis (HP:0100582) | 2.15261716 |
| 96 | Hepatosplenomegaly (HP:0001433) | 2.12737594 |
| 97 | Granulocytopenia (HP:0001913) | 2.11650707 |
| 98 | Abnormality of T cells (HP:0002843) | 2.11548569 |
| 99 | Severe combined immunodeficiency (HP:0004430) | 2.10440180 |
| 100 | Short phalanx of the thumb (HP:0009660) | 2.10207573 |
| 101 | Anorexia (HP:0002039) | 2.09626024 |
| 102 | Recurrent lower respiratory tract infections (HP:0002783) | 2.09264475 |
| 103 | Bone pain (HP:0002653) | 2.07033525 |
| 104 | Agnosia (HP:0010524) | 2.05629051 |
| 105 | Fused cervical vertebrae (HP:0002949) | 2.05004842 |
| 106 | Abnormality of the nasal mucosa (HP:0000433) | 2.04424933 |
| 107 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.03254967 |
| 108 | Absent thumb (HP:0009777) | 2.03213717 |
| 109 | Nephritis (HP:0000123) | 2.02064674 |
| 110 | Congenital sensorineural hearing impairment (HP:0008527) | 2.00819275 |
| 111 | B lymphocytopenia (HP:0010976) | 1.99694611 |
| 112 | IgG deficiency (HP:0004315) | 1.97486010 |
| 113 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.96836644 |
| 114 | Abnormality of the renal collecting system (HP:0004742) | 1.96145947 |
| 115 | Gangrene (HP:0100758) | 1.96080235 |
| 116 | Chest pain (HP:0100749) | 1.95570244 |
| 117 | Deformed sella turcica (HP:0002681) | 1.95423750 |
| 118 | Agitation (HP:0000713) | 1.94905606 |
| 119 | Premature loss of primary teeth (HP:0006323) | 1.94789589 |
| 120 | Myocardial infarction (HP:0001658) | 1.92720919 |
| 121 | Osteolytic defects of the hand bones (HP:0009699) | 1.92714135 |
| 122 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.92714135 |
| 123 | Progressive visual loss (HP:0000529) | 1.91751304 |
| 124 | Combined immunodeficiency (HP:0005387) | 1.90485941 |
| 125 | Increased IgE level (HP:0003212) | 1.90271496 |
| 126 | Tetraparesis (HP:0002273) | 1.89992129 |
| 127 | Stomach cancer (HP:0012126) | 1.89937994 |
| 128 | Menorrhagia (HP:0000132) | 1.88801732 |
| 129 | Sepsis (HP:0100806) | 1.88504553 |
| 130 | Genetic anticipation (HP:0003743) | 1.88300700 |
| 131 | Hypergammaglobulinemia (HP:0010702) | 1.88193147 |
| 132 | Albinism (HP:0001022) | 1.84660226 |
| 133 | Skin ulcer (HP:0200042) | 1.84083498 |
| 134 | Abnormality of DNA repair (HP:0003254) | 1.83766080 |
| 135 | Polyneuropathy (HP:0001271) | 1.83072654 |
| 136 | Keratoconjunctivitis sicca (HP:0001097) | 1.80084442 |
| 137 | Pulmonary embolism (HP:0002204) | 1.80031442 |
| 138 | Increased IgM level (HP:0003496) | 1.79969399 |
| 139 | Pancreatic cysts (HP:0001737) | 1.79790345 |
| 140 | Porencephaly (HP:0002132) | 1.79567977 |
| 141 | Duplicated collecting system (HP:0000081) | 1.79215837 |
| 142 | Hemiplegia (HP:0002301) | 1.78689500 |
| 143 | Spondylolisthesis (HP:0003302) | 1.78234202 |
| 144 | Eosinophilia (HP:0001880) | 1.77783916 |
| 145 | Absent frontal sinuses (HP:0002688) | 1.77613419 |
| 146 | Episodic fever (HP:0001954) | 1.77260285 |
| 147 | Abnormality of the thoracic spine (HP:0100711) | 1.76574599 |
| 148 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.76252007 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.18088998 |
| 2 | IRAK4 | 4.00667587 |
| 3 | MAP4K1 | 3.95296649 |
| 4 | BLK | 3.63264654 |
| 5 | MAP3K14 | 3.23530279 |
| 6 | IRAK3 | 3.09703649 |
| 7 | ADRBK2 | 3.08990521 |
| 8 | TBK1 | 2.95393587 |
| 9 | ERN1 | 2.92171717 |
| 10 | TYK2 | 2.79540565 |
| 11 | FRK | 2.63296832 |
| 12 | KIT | 2.48761113 |
| 13 | ACVR1B | 2.37791570 |
| 14 | IKBKE | 2.15172097 |
| 15 | TAOK3 | 2.12779268 |
| 16 | FES | 1.97959711 |
| 17 | GRK1 | 1.94953995 |
| 18 | CSK | 1.84090185 |
| 19 | IKBKB | 1.80487159 |
| 20 | TLK1 | 1.77389561 |
| 21 | SIK2 | 1.75733774 |
| 22 | JAK3 | 1.75183857 |
| 23 | MAP3K13 | 1.74292355 |
| 24 | ZAP70 | 1.69715637 |
| 25 | EPHB1 | 1.63675356 |
| 26 | FGR | 1.63564523 |
| 27 | HCK | 1.55442464 |
| 28 | BTK | 1.54710666 |
| 29 | JAK1 | 1.51468329 |
| 30 | TGFBR2 | 1.50299270 |
| 31 | TNK2 | 1.49244775 |
| 32 | SYK | 1.48377801 |
| 33 | CSF1R | 1.36556038 |
| 34 | TXK | 1.34033899 |
| 35 | PIM2 | 1.31233201 |
| 36 | TRIB3 | 1.30548884 |
| 37 | TEC | 1.24280023 |
| 38 | CAMK1D | 1.22328640 |
| 39 | BMPR2 | 1.21631697 |
| 40 | STK10 | 1.18810393 |
| 41 | TTN | 1.16735969 |
| 42 | RIPK1 | 1.16027432 |
| 43 | CHUK | 1.12228682 |
| 44 | BMPR1B | 1.11035083 |
| 45 | MAP2K3 | 1.09923279 |
| 46 | MATK | 1.08844397 |
| 47 | LYN | 1.08066532 |
| 48 | CLK1 | 1.08063100 |
| 49 | PINK1 | 1.04096969 |
| 50 | LCK | 1.03686909 |
| 51 | JAK2 | 1.02677599 |
| 52 | PIM1 | 1.00217404 |
| 53 | CAMK1G | 0.98363279 |
| 54 | RPS6KA4 | 0.96469566 |
| 55 | MAP2K6 | 0.94953223 |
| 56 | MAP3K11 | 0.92766679 |
| 57 | ABL2 | 0.92147843 |
| 58 | MARK3 | 0.91376202 |
| 59 | PTK6 | 0.90253107 |
| 60 | OXSR1 | 0.88676524 |
| 61 | DAPK2 | 0.87986577 |
| 62 | BMX | 0.86975426 |
| 63 | RPS6KA6 | 0.84601331 |
| 64 | ZAK | 0.83195030 |
| 65 | CDC42BPA | 0.80122024 |
| 66 | GRK6 | 0.79237625 |
| 67 | RPS6KC1 | 0.78864762 |
| 68 | RPS6KL1 | 0.78864762 |
| 69 | MAP3K10 | 0.78043695 |
| 70 | MAP4K2 | 0.73644118 |
| 71 | PKN2 | 0.68935537 |
| 72 | PRKD2 | 0.67551770 |
| 73 | MST1R | 0.66756425 |
| 74 | PRKCQ | 0.65797957 |
| 75 | CDK12 | 0.63722195 |
| 76 | MAP2K4 | 0.63538640 |
| 77 | PAK4 | 0.62793866 |
| 78 | NUAK1 | 0.61596234 |
| 79 | TRPM7 | 0.61574265 |
| 80 | EGFR | 0.59909760 |
| 81 | CAMKK2 | 0.59156352 |
| 82 | ADRBK1 | 0.58972608 |
| 83 | NME2 | 0.58883917 |
| 84 | GRK7 | 0.58300487 |
| 85 | RPS6KA2 | 0.58031103 |
| 86 | ABL1 | 0.57370007 |
| 87 | PRKCD | 0.57099577 |
| 88 | DYRK3 | 0.56729666 |
| 89 | STK11 | 0.55942538 |
| 90 | INSRR | 0.54713058 |
| 91 | MAPK13 | 0.54606559 |
| 92 | CDK9 | 0.54413826 |
| 93 | LRRK2 | 0.54175986 |
| 94 | SIK3 | 0.53162608 |
| 95 | WNK3 | 0.52685270 |
| 96 | MOS | 0.52454739 |
| 97 | TGFBR1 | 0.51815386 |
| 98 | YES1 | 0.51282269 |
| 99 | ITK | 0.48956185 |
| 100 | DAPK1 | 0.48943669 |
| 101 | MAPK4 | 0.47784373 |
| 102 | MAP3K1 | 0.47708388 |
| 103 | CDK19 | 0.46690864 |
| 104 | PIK3CG | 0.46649426 |
| 105 | FLT3 | 0.46623502 |
| 106 | EPHA3 | 0.44247657 |
| 107 | WNK4 | 0.44104266 |
| 108 | NEK9 | 0.43969317 |
| 109 | EIF2AK2 | 0.43679816 |
| 110 | MAPKAPK2 | 0.43476095 |
| 111 | MAP3K5 | 0.42402489 |
| 112 | CDK6 | 0.41638687 |
| 113 | DAPK3 | 0.40559010 |
| 114 | PTK2B | 0.40521388 |
| 115 | IRAK2 | 0.39983077 |
| 116 | CAMKK1 | 0.39396503 |
| 117 | FYN | 0.39226578 |
| 118 | KSR2 | 0.36616137 |
| 119 | IRAK1 | 0.35703168 |
| 120 | STK4 | 0.34664607 |
| 121 | PRKG2 | 0.34256349 |
| 122 | NLK | 0.33918377 |
| 123 | PDK1 | 0.33832664 |
| 124 | PRKAA2 | 0.32827528 |
| 125 | HIPK2 | 0.32648507 |
| 126 | PDPK1 | 0.32628652 |
| 127 | SCYL2 | 0.31934714 |
| 128 | PRKCH | 0.31798850 |
| 129 | MAP2K1 | 0.31657969 |
| 130 | MAPK12 | 0.30989706 |
| 131 | TAOK2 | 0.30361836 |
| 132 | TAOK1 | 0.30068436 |
| 133 | PBK | 0.29222834 |
| 134 | SGK2 | 0.28993382 |
| 135 | MAP2K2 | 0.28895093 |
| 136 | MAP3K3 | 0.28768503 |
| 137 | MAP3K4 | 0.27712039 |
| 138 | IGF1R | 0.27525936 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.51550561 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.21286077 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.71752236 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.51150293 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.48828031 |
| 6 | Lysosome_Homo sapiens_hsa04142 | 2.45480601 |
| 7 | Tuberculosis_Homo sapiens_hsa05152 | 2.45088671 |
| 8 | Pertussis_Homo sapiens_hsa05133 | 2.38617148 |
| 9 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.25581385 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.23980910 |
| 11 | Malaria_Homo sapiens_hsa05144 | 2.13618252 |
| 12 | Legionellosis_Homo sapiens_hsa05134 | 2.13096304 |
| 13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.12100425 |
| 14 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.11286467 |
| 15 | Phagosome_Homo sapiens_hsa04145 | 1.87467840 |
| 16 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.85277314 |
| 17 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.84501604 |
| 18 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.81612438 |
| 19 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.79513828 |
| 20 | Measles_Homo sapiens_hsa05162 | 1.76157907 |
| 21 | Influenza A_Homo sapiens_hsa05164 | 1.66765651 |
| 22 | Asthma_Homo sapiens_hsa05310 | 1.66189764 |
| 23 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.61743853 |
| 24 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.61644898 |
| 25 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.57740763 |
| 26 | Salmonella infection_Homo sapiens_hsa05132 | 1.57722943 |
| 27 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.57430636 |
| 28 | Shigellosis_Homo sapiens_hsa05131 | 1.56650447 |
| 29 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.54723294 |
| 30 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.52135664 |
| 31 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.51864071 |
| 32 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.48398287 |
| 33 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.40407225 |
| 34 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.38090680 |
| 35 | Apoptosis_Homo sapiens_hsa04210 | 1.37323753 |
| 36 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.32279587 |
| 37 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.28483148 |
| 38 | * Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.22118603 |
| 39 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.20266016 |
| 40 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.18212069 |
| 41 | Allograft rejection_Homo sapiens_hsa05330 | 1.17674932 |
| 42 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.11662017 |
| 43 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.09906966 |
| 44 | Hepatitis B_Homo sapiens_hsa05161 | 1.09342538 |
| 45 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.08400211 |
| 46 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.08203270 |
| 47 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.06380782 |
| 48 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.00985791 |
| 49 | Hepatitis C_Homo sapiens_hsa05160 | 0.99757955 |
| 50 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.99324939 |
| 51 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.98443027 |
| 52 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.95440609 |
| 53 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.94049648 |
| 54 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.92995021 |
| 55 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.92823878 |
| 56 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.92746172 |
| 57 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.91094556 |
| 58 | Platelet activation_Homo sapiens_hsa04611 | 0.88369508 |
| 59 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.88244568 |
| 60 | Amoebiasis_Homo sapiens_hsa05146 | 0.87961379 |
| 61 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.87761148 |
| 62 | Viral myocarditis_Homo sapiens_hsa05416 | 0.83940445 |
| 63 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.83642138 |
| 64 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.82393064 |
| 65 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.82021485 |
| 66 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.81068288 |
| 67 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.79696822 |
| 68 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.79316935 |
| 69 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.74470086 |
| 70 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.72059346 |
| 71 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.71213214 |
| 72 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.69184359 |
| 73 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.68975410 |
| 74 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.67918450 |
| 75 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.66531894 |
| 76 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.65178511 |
| 77 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.64729644 |
| 78 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.64577498 |
| 79 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.64298224 |
| 80 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.61072995 |
| 81 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.60776744 |
| 82 | Phototransduction_Homo sapiens_hsa04744 | 0.59275567 |
| 83 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.58953411 |
| 84 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.52950552 |
| 85 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.51557309 |
| 86 | Endocytosis_Homo sapiens_hsa04144 | 0.50056202 |
| 87 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.49849346 |
| 88 | Insulin resistance_Homo sapiens_hsa04931 | 0.48170832 |
| 89 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.45055344 |
| 90 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.44776441 |
| 91 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.44398556 |
| 92 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.44349895 |
| 93 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.43758143 |
| 94 | Prion diseases_Homo sapiens_hsa05020 | 0.43714367 |
| 95 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.42296440 |
| 96 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.42255163 |
| 97 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.41246238 |
| 98 | Morphine addiction_Homo sapiens_hsa05032 | 0.41184835 |
| 99 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.40858571 |
| 100 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.39108472 |
| 101 | Mineral absorption_Homo sapiens_hsa04978 | 0.38751320 |
| 102 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.36835172 |
| 103 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.35670410 |
| 104 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.32828200 |
| 105 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.31865966 |
| 106 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.31803182 |
| 107 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.31018137 |
| 108 | HTLV-I infection_Homo sapiens_hsa05166 | 0.30870557 |
| 109 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.29100435 |
| 110 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.28408696 |
| 111 | ABC transporters_Homo sapiens_hsa02010 | 0.27168202 |
| 112 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.27084562 |
| 113 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.27029725 |
| 114 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.26625289 |
| 115 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.26609995 |
| 116 | Colorectal cancer_Homo sapiens_hsa05210 | 0.26262860 |
| 117 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.25534776 |
| 118 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.24873147 |
| 119 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.24729646 |
| 120 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.24233529 |
| 121 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.23741472 |
| 122 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.22398027 |
| 123 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.18022428 |
| 124 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.17593799 |
| 125 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.17254447 |
| 126 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.16726376 |
| 127 | Olfactory transduction_Homo sapiens_hsa04740 | 0.14900296 |
| 128 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.13687177 |

